1. Home
  2. CARG vs CRNX Comparison

CARG vs CRNX Comparison

Compare CARG & CRNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CarGurus Inc.

CARG

CarGurus Inc.

HOLD

Current Price

$29.92

Market Cap

3.3B

Sector

Technology

ML Signal

HOLD

Logo Crinetics Pharmaceuticals Inc.

CRNX

Crinetics Pharmaceuticals Inc.

HOLD

Current Price

$38.45

Market Cap

3.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CARG
CRNX
Founded
2005
2008
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.3B
3.9B
IPO Year
2017
2018

Fundamental Metrics

Financial Performance
Metric
CARG
CRNX
Price
$29.92
$38.45
Analyst Decision
Buy
Strong Buy
Analyst Count
11
8
Target Price
$38.32
$76.75
AVG Volume (30 Days)
989.7K
1.3M
Earning Date
05-07-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
675.00
N/A
EPS
0.34
N/A
Revenue
$316,861,000.00
$1,039,000.00
Revenue This Year
$13.89
$720.10
Revenue Next Year
$8.91
$184.67
P/E Ratio
$91.59
N/A
Revenue Growth
59.92
N/A
52 Week Low
$26.39
$25.83
52 Week High
$39.42
$57.99

Technical Indicators

Market Signals
Indicator
CARG
CRNX
Relative Strength Index (RSI) 26.28 47.31
Support Level $28.80 $33.19
Resistance Level $36.22 $43.71
Average True Range (ATR) 1.34 2.30
MACD -0.94 -0.28
Stochastic Oscillator 0.24 31.68

Price Performance

Historical Comparison
CARG
CRNX

About CARG CarGurus Inc.

CarGurus Inc is a company that acts as an online automotive marketplace connecting buyers and sellers of new and used cars. It provides three types of marketplace Listing products, Restricted Listings, and Enhanced or Featured Listings, through which it offers real-time and historical data analyzing the connections and pricing analysis. The listing platforms offer auto manufacturers and others to buy advertising on the company's site and target consumers based on the make, model, and zip code of the cars. The company operates through two segments, namely U.S. Marketplace and Digital Wholesale. It generates maximum revenue from the U.S. Marketplace segment. Geographically, the company derives its key revenue from the United States and the rest from international markets.

About CRNX Crinetics Pharmaceuticals Inc.

Crinetics Pharmaceuticals Inc is a commercial-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. Its main product, Palsonify (paltusotine), is a once-daily, oral treatment approved by the FDA for adults with acromegaly who have had an inadequate response to surgery and/or for whom surgery is not an option. Additionally, the company's development pipeline includes several programs, including a late-stage investigational candidate, atumelnant, currently in development for CAH and ADCS, and CRN09682, a NDC candidate that is being developed to treat SST2-expressing NETs and other SST2-expressing solid tumors.

Share on Social Networks: